Spyre Therapeutics (SYRE) Debt Ratio (2023 - 2025)
Spyre Therapeutics' Debt Ratio history spans 3 years, with the latest figure at 0.03 for Q4 2025.
- For Q4 2025, Debt Ratio fell 28.82% year-over-year to 0.03; the TTM value through Dec 2025 reached 0.03, down 28.82%, while the annual FY2025 figure was 0.03, 28.82% down from the prior year.
- Debt Ratio reached 0.03 in Q4 2025 per SYRE's latest filing, up from 0.02 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.67 in Q2 2023 to a low of 0.0 in Q4 2023.
- Average Debt Ratio over 3 years is 0.1, with a median of 0.04 recorded in 2023.
- Peak YoY movement for Debt Ratio: crashed 99.1% in 2024, then surged 1736.21% in 2025.
- A 3-year view of Debt Ratio shows it stood at 0.0 in 2023, then surged by 913.7% to 0.04 in 2024, then fell by 28.82% to 0.03 in 2025.
- Per Business Quant, the three most recent readings for SYRE's Debt Ratio are 0.03 (Q4 2025), 0.02 (Q3 2025), and 0.11 (Q2 2025).